Skip to content

Clinical trials

Phase 1/2 Autistic Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Phase 1/2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20051
20081
20092
20161
20171
20191
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Enrolling by invitation1
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Ageless Regenerative Institute1
Black Tie Medical, Inc.1
Boston Children's Hospital1
Children's Hospital Medical Center, Cincinnati1
Chugani, Diane C.1
Nambudripad's Allergy Research Foundation1
National Institute of Mental Health (NIMH)1
Penn State University1
Southwest College of Naturopathic Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder13
Autism Spectrum Disorder4
Asperger Syndrome2
Child Development Disorders, Pervasive2
Intellectual Disability2
Learning Disabilities2
Anxiety Disorders1
Cognition Disorders1
Cognitive Dysfunction1
Food Hypersensitivity1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.